Cargando…

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland

Detalles Bibliográficos
Autores principales: Perez-Saez, Javier, Lauer, Stephen A, Kaiser, Laurent, Regard, Simon, Delaporte, Elisabeth, Guessous, Idris, Stringhini, Silvia, Azman, Andrew S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833057/
https://www.ncbi.nlm.nih.gov/pubmed/32679085
http://dx.doi.org/10.1016/S1473-3099(20)30584-3
_version_ 1783641978308657152
author Perez-Saez, Javier
Lauer, Stephen A
Kaiser, Laurent
Regard, Simon
Delaporte, Elisabeth
Guessous, Idris
Stringhini, Silvia
Azman, Andrew S
author_facet Perez-Saez, Javier
Lauer, Stephen A
Kaiser, Laurent
Regard, Simon
Delaporte, Elisabeth
Guessous, Idris
Stringhini, Silvia
Azman, Andrew S
author_sort Perez-Saez, Javier
collection PubMed
description
format Online
Article
Text
id pubmed-7833057
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78330572021-01-26 Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland Perez-Saez, Javier Lauer, Stephen A Kaiser, Laurent Regard, Simon Delaporte, Elisabeth Guessous, Idris Stringhini, Silvia Azman, Andrew S Lancet Infect Dis Correspondence Elsevier Ltd. 2021-04 2020-07-14 /pmc/articles/PMC7833057/ /pubmed/32679085 http://dx.doi.org/10.1016/S1473-3099(20)30584-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Perez-Saez, Javier
Lauer, Stephen A
Kaiser, Laurent
Regard, Simon
Delaporte, Elisabeth
Guessous, Idris
Stringhini, Silvia
Azman, Andrew S
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title_full Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title_fullStr Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title_full_unstemmed Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title_short Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
title_sort serology-informed estimates of sars-cov-2 infection fatality risk in geneva, switzerland
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833057/
https://www.ncbi.nlm.nih.gov/pubmed/32679085
http://dx.doi.org/10.1016/S1473-3099(20)30584-3
work_keys_str_mv AT perezsaezjavier serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT lauerstephena serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT kaiserlaurent serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT regardsimon serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT delaporteelisabeth serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT guessousidris serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT stringhinisilvia serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT azmanandrews serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland
AT serologyinformedestimatesofsarscov2infectionfatalityriskingenevaswitzerland